
Loading, please wait...

Loading, please wait...

Acute graft-versus-host disease (aGVHD) remains a life-threatening complication for patients undergoing allogeneic hematopoietic stem cell transplantation. Recent experimental evidence suggests that fructose intake and aGVHD severity have a direct, negative correlation. Researchers discovered that high fructose consumption significantly increases mortality and clinical scores in animal models. This dietary factor acts as a trigger for a series of inflammatory events that compromise the success of transplantation.
High fructose diets induce a profound imbalance in the gut microbiota. Specifically, this dietary pattern enhances bacterial translocation by impairing the intestinal epithelial barrier. Fecal microbiota transplantation from subjects fed a high-fructose diet was sufficient to reproduce these barrier disruptions in recipients. Even after gut microbiota depletion, fructose continued to exacerbate disease severity. These findings highlight that fructose directly affects the host environment beyond its role in microbial shifts.
The study also investigated how fructose affects innate immune cells. Interestingly, T-cells did not respond directly to fructose stimulation. However, macrophages showed significant inflammatory changes. Fructose exposure stabilized hypoxia-inducible factor 1-alpha (HIF-1α) through the production of mitochondrial reactive oxygen species. Consequently, this metabolic shift increased glycolysis and the secretion of inflammatory cytokines like IL-6 and TNF-α. These activated macrophages subsequently enhanced T-cell proliferation and Th1/Th17 differentiation, further fueling the systemic inflammatory response.
Correlation analyses revealed specific bacterial families, such as Akkermansiaceae and Erysipelotrichaceae, that link fructose consumption to harmful metabolites. Furthermore, researchers found that depleting both macrophages and the gut microbiota significantly reversed the severity of the disease. Therefore, precise dietary adjustments may serve as a potential therapeutic strategy. Restricting fructose could alleviate the hyper-inflammatory state and improve survival rates in transplant recipients.
A high-fructose diet aggravates the disease by disrupting the gut microbiome and damaging the intestinal barrier. This leads to increased bacterial translocation and a heightened inflammatory response mediated by macrophages.
Fructose causes metabolic reprogramming in macrophages. It stabilizes HIF-1α, which increases glycolysis and the production of pro-inflammatory cytokines, eventually promoting aggressive T-cell responses.
Yes, the study suggests that restricting fructose intake may reduce gut dysbiosis and limit macrophage-mediated inflammation, offering a potential way to manage aGVHD severity effectively.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Wu K et al. Overconsumption of fructose aggravates acute GVHD by inducing gut dysbiosis and promoting macrophage-mediated inflammatory response. Gut Microbes. 2026 Dec 31. doi: 10.1080/19490976.2026.2642459. PMID: 41826266.
Hansson GC, Johansson ME. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Gut Microbes. 2010.
Lin et al. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol. 2021.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research shows high fructose intake aggravates acute GVHD by inducing gut dysbiosis and macrophage-mediated inflammation....
7 months ago

A breakthrough peer-reviewed study demonstrates that a sequential AI diagnosis system can mirror real-world clinical reasoning. By ordering stepwise tests and updating hypotheses dynamically, this multi-agent orchestrator achieved superior diagnostic accuracy while reducing investigative costs.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday